IJGPNInternational Journal of General Practice Nursing2981-94152981-9423Bio-Byword Scientific Publishing Pty. Ltd.10.26689/ijgpn.v4i2.15057ArticleImpact of Standardized Anticoagulation Management Optimization on the Operational Quality and Clinical Outcomes of Continuous Renal Replacement Therapyhttps://artdesignp.com/journal/IJGPN/4/2/10.26689/ijgpn.v4i2.15057DengHongfei,WangZheng,FengKe,LiangZhang,JiangWenkai2026422026-05-31Objective: To evaluate the impact of optimizing a standardized anticoagulation management protocol on the operational quality of continuous renal replacement therapy (CRRT) and related clinical outcomes. Methods: This was a single-center retrospective quality improvement study. Adult patients who underwent CRRT for ≥24 hours in the Intensive Care Unit of Linfen People’s Hospital between 2023 and 2025 were included. According to the implementation stages of the optimized anticoagulation management protocol, patients were divided into three annual groups. The distribution of anticoagulation strategies, filter lifespan per session, incidence of unplanned circuit interruption, bleeding complications, and ICU length of stay were compared among the three groups. Results: A total of 289 patients were included. With the implementation of the standardized anticoagulation management protocol, the proportion of regional citrate anticoagulation increased from 45.5% in 2023 to 83.5% in 2025. Filter lifespan was significantly prolonged (45.3 ± 12.1 h vs 72.4 ± 11.6 h, P < 0.001), while the incidence of unplanned circuit interruption and bleeding complications decreased over time (both P < 0.05). ICU length of stay also showed a downward trend (P = 0.009). Conclusion: The establishment and implementation of a CRRT-centered standardized anticoagulation management protocol were associated with prolonged filter lifespan, reduced complication rates, and improved operational quality of CRRT. This management approach may enhance the safety of blood purification therapy in critically ill patients in the ICU.

Prowle JR, Schneider A, Bellomo R, 2011, Clinical Review: Optimal Dose of Continuous Renal Replacement Therapy in Acute Kidney Injury. Critical Care, 15(2): 207. https://doi.org/10.1186/cc9415

Ronco C, Bellomo R, Kellum JA, 2019, Acute Kidney Injury. Lancet, 394(10212): 1949–1964. https://doi.org/10.1016/S0140-6736(19)32563-2

Zhou Z, Liu C, Yang Y, et al., 2023, Anticoagulation Options for Continuous Renal Replacement Therapy in Critically Ill Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Critical Care, 27(1): 222. https://doi.org/10.1186/s13054-023-04519-1

Zarbock A, Küllmar M, Kindgen-Milles D, et al., 2020, Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients with Acute Kidney Injury: A Randomized Clinical Trial. JAMA, 324(16): 1629–1639. https://doi.org/10.1001/jama.2020.18618

Wald R, Beaubien-Souligny W, Chanchlani R, et al., 2022, Delivering Optimal Renal Replacement Therapy to Critically Ill Patients with Acute Kidney Injury. Intensive Care Medicine, 48(10): 1368–1381. https://doi.org/10.1007/s00134-022-06851-6

Bai M, Zhou M, He L, et al., 2015, Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: An Updated Meta-analysis of RCTs. Intensive Care Medicine, 41(12): 2098–2110. https://doi.org/10.1007/s00134-015-4099-0

Liu C, Mao Z, Kang H, et al., 2016, Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials. Critical Care, 20(1): 144. https://doi.org/10.1186/s13054-016-1299-0

Hafner S, Stahl W, Fels T, et al., 2015, Implementation of Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation on a Surgical and Trauma Intensive Care Unit: Impact on Clinical and Economic Aspects-an Observational Study. Journal of Intensive Care, 3(1): 35. https://doi.org/10.1186/s40560-015-0102-7

Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al., 2009, Citrate Anticoagulation for Continuous Venovenous Hemofiltration. Critical Care Medicine, 37(2): 545–552. https://doi.org/10.1097/CCM.0b013e3181953c5e

Clark E, Molnar AO, Joannes-Boyau O, et al., 2014, High-volume Hemofiltration for Septic Acute Kidney Injury: A Systematic Review and Meta-analysis. Critical Care, 18(1): R7. https://doi.org/10.1186/cc13184

Gaudry S, Hajage D, Schortgen F, et al., 2016, Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. The New England Journal of Medicine, 375(2): 122–133. https://doi.org/10.1056/NEJMoa1603017